IL1B and Hyperglycemia: Chronic and inadequately treated hyperglycemia in patients diagnosed with DM can activate inflammatory responses through citokine production (TNF-α, NFkB, IL-1, IL-6, etc.)from various types of cells (such as macrophages, lymphocytes, granulocytes, fibroblasts, mast and endothelial cells).